Significant Developments: Henlius Biotech (02696) announced that the first patient has been dosed in China in the Phase 1b/2 clinical study of HLX701 combined with cetuximab and chemotherapy for the treatment of advanced colorectal cancer. CStone Pharmaceuticals-B (02616) disclosed the latest clinical progress and key Phase I/II clinical data for its PD-1/VEGF/CTLA-4 trispecific antibody CS2009. Hengrui Pharmaceuticals (01276) reported that HRS9531 injection has received approval to commence clinical trials. Henry (Hong Kong) Holdings (00396) announced that Li Yujun may acquire approximately 58.36% of the company's shares, with trading resuming on March 27. BioMap-B (02315) partner NEOK Bio received FDA IND clearance for its bispecific antibody ADC NEOK002, marking a key milestone in the collaboration. Humon Gold (03788) plans to acquire the remaining 9.56% stake in Humon Gold Limited for HK$814.6 million to gain 100% ownership of the gold business. Livzon Pharmaceutical (01513) announced that Brexpiprazole Microspheres for Injection has received approval for clinical trials. Shanghai Pharmaceuticals (02607) reported that Diprophylline Injection has been approved for production.

Business Performance: Baiji Pharmaceuticals (02659) reported 2025 results, highlighting rapid progress in its core pipeline and the completion of the first batch order delivery for SJ02. China Mobile (00941) released its annual results, with profit attributable to shareholders decreasing by 0.9% to RMB 137.095 billion. CNOOC (00883) announced 2025 results, showing a net profit attributable to shareholders of RMB 122.082 billion, down 11.5% year-on-year, with a final dividend of HK$0.55 per share. Beijing Enterprises (00392) reported annual results, with profit attributable to shareholders declining 1.31% to RMB 5.056 billion, while its core business maintained an industry-leading position. Pony.ai-W (02026) achieved revenue of $90 million in 2025, a 20.0% increase year-on-year. Meituan-W (03690) released annual results, with revenue growing 8.1% to RMB 364.9 billion. Ping An Insurance (02318) announced annual results, with net profit attributable to shareholders rising 6.45% to RMB 134.778 billion. Innovent Biologics (01801) reported 2025 results, achieving a net profit of RMB 813.6 million, marking its first full-year profit. Qingci Games (06633) saw annual net profit surge 138% to RMB 122 million, driven by the long-term operation of "Strongest Snail" and the launch of a Disney IP collaboration. PICC Group (01339) released annual results, with net profit attributable to shareholders increasing 9.62% to RMB 46.207 billion. Texhong International Group (02678) announced annual results, with profit attributable to shareholders rising 63.05% to RMB 913 million. SMIC (00981) reported annual results, with net profit attributable to shareholders increasing 39% to $685 million. Chow Sang Sang (00116) released annual results, with profit attributable to shareholders surging 113.2% to HK$1.717 billion. China Reinsurance (02328) announced 2025 results, with net profit rising 25.5% to RMB 40.377 billion and a final dividend of HK$0.44 per share. Concord New Energy (00182) accelerated its global layout in 2025, with improved cash flow and significant cost reduction and efficiency gains. Huadian Power International (01071) reported annual results, with net profit attributable to shareholders increasing 1.4% to RMB 6.07 billion. UISEE (09678) achieved revenue of approximately RMB 1.211 billion in 2025, up 29% year-on-year, with large model-related business revenue experiencing explosive growth of over 10 times. China Pacific Insurance (02601) announced 2025 results, with net profit attributable to shareholders increasing 19.0% to RMB 53.505 billion. MGP (01318) released annual results, with profit attributable to shareholders rising 36.73% to RMB 1.204 billion. Qingdao Bank (03866) reported 2025 results, with net profit attributable to shareholders increasing 21.66% to RMB 5.188 billion. Maoyan Entertainment (01896) announced annual results, with profit attributable to shareholders surging 209.86% to RMB 564 million. CITIC Securities (06030) released 2025 results, with net profit attributable to shareholders rising 38.57% to RMB 30.076 billion. Chizicheng Technology (09911) reported annual results, with profit attributable to shareholders increasing 94.57% to RMB 935 million. BioMap (02315) achieved a leap in profitability in 2025, with net profit soaring 416.37%, establishing a "China solution" for global new drug R&D infrastructure. Everbright Securities (06178) released annual results, with net profit attributable to shareholders rising 21.77% to RMB 3.724 billion. Huishang Bank (03698) announced annual results, with net profit attributable to shareholders increasing 7.21% to RMB 16.525 billion. Haitian Flavouring & Food (03288) reported 2025 results, with net profit attributable to shareholders rising 10.95% to RMB 7.038 billion. Jiufang Zhitong Holdings (09636) released annual results, with profit attributable to shareholders surging 238.5% to RMB 922 million. China Securities (06066) announced 2025 results, with net profit attributable to shareholders increasing 30.68% to RMB 9.439 billion. Yunfeng Financial (00376) reported 2025 results, with profit attributable to shareholders rising 39% to HK$653 million. Air China (00753) released 2025 results, with loss attributable to shareholders widening 668.8% to RMB 1.788 billion. Shandong Gold (01787) announced 2025 results, with net profit attributable to shareholders increasing approximately 60.57% to approximately RMB 4.739 billion. Chengdu Expressway (01785) reported annual results, with net profit attributable to shareholders rising 6.33% to RMB 552 million. ZhongAn Smart Living (02271) achieved revenue of approximately RMB 472 million in 2025, up 14.6% year-on-year, with managed area increasing to 22.09 million square meters. Weilong Delicious Food (09985) released annual results, with profit attributable to shareholders rising 33.38% to RMB 1.425 billion. Zhou Hei Ya (01458) announced annual results, with annual profit attributable to shareholders increasing 59.6% to RMB 157 million, and store count returning to over 3,000. Cloud Factory (02512) reported annual results, with revenue increasing 33.3% to RMB 943 million. Haier Smart Home (06690) released annual results, with profit attributable to shareholders rising 4.39% to RMB 19.553 billion, and proposed a final dividend of RMB 0.8867 per 10 shares. CGU Mining (01164) announced annual results, with profit attributable to shareholders increasing 32.39% to HK$453 million. Zai Lab (09688) reported annual results, with total revenue rising 15% to $460 million, and positive progress across all product pipelines. Vobile Group (03738) released annual results, with net profit surging 33.57% to HK$212 million, driven by AI and Web3 enabling the release of content asset value.